These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 1672254)

  • 21. c-erbB-2 oncogene related to p53 expression, cell proliferation and prognosis in breast cancer.
    Lipponen HJ; Aaltomaa S; Syrjänen S; Syrjänen K
    Anticancer Res; 1993; 13(4):1147-52. PubMed ID: 8102517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness.
    Sugano S; Mukai K; Tsuda H; Hirohashi S; Furuya S; Shimosato Y; Ebihara S; Takeyama I
    Laryngoscope; 1992 Aug; 102(8):923-7. PubMed ID: 1353853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. c-myc oncogene product expression and prognosis in operable breast cancer.
    Locker AP; Dowle CS; Ellis IO; Elston CW; Blamey RW; Sikora K; Evan G; Robins RA
    Br J Cancer; 1989 Nov; 60(5):669-72. PubMed ID: 2679850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An evaluation of immunoreactivity for c-erbB-2 protein as a marker of poor short-term prognosis in breast cancer.
    Walker RA; Gullick WJ; Varley JM
    Br J Cancer; 1989 Sep; 60(3):426-9. PubMed ID: 2571356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proliferating cell nuclear antigen in breast lesions: correlation of c-erbB-2 oncoprotein and EGF receptor and its clinicopathological significance in breast cancer.
    Shrestha P; Yamada K; Wada T; Maeda S; Watatani M; Yasutomi M; Takagi H; Mori M
    Virchows Arch A Pathol Anat Histopathol; 1992; 421(3):193-202. PubMed ID: 1357812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.
    Gusterson BA; Gelber RD; Goldhirsch A; Price KN; Säve-Söderborgh J; Anbazhagan R; Styles J; Rudenstam CM; Golouh R; Reed R
    J Clin Oncol; 1992 Jul; 10(7):1049-56. PubMed ID: 1351538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. c-erbB-2 expression in different histological types of invasive breast carcinoma.
    Soomro S; Shousha S; Taylor P; Shepard HM; Feldmann M
    J Clin Pathol; 1991 Mar; 44(3):211-4. PubMed ID: 1672872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. c-erbB2 expression in correlation to other biological parameters of breast cancer.
    Marx D; Schauer A; Reiche C; May A; Ummenhofer L; Reles A; Rauschecker H; Sauer R; Schumacher M
    J Cancer Res Clin Oncol; 1990; 116(1):15-20. PubMed ID: 1968902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of the c-erbB-2 (HER-2/neu) oncoprotein in human prostatic carcinoma.
    Kuhn EJ; Kurnot RA; Sesterhenn IA; Chang EH; Moul JW
    J Urol; 1993 Nov; 150(5 Pt 1):1427-33. PubMed ID: 8105108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of c-erbB-2 expression in node negative breast cancer.
    Bianchi S; Paglierani M; Zampi G; Cardona G; Cataliotti L; Bonardi R; Ciatto S
    Br J Cancer; 1993 Mar; 67(3):625-9. PubMed ID: 8094977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term survival in breast cancer related to overexpression of the c-erbB-2 oncoprotein: an immunohistochemical study using monoclonal antibody NCL-CB11.
    Dykins R; Corbett IP; Henry JA; Wright C; Yuan J; Hennessy C; Lennard TJ; Angus B; Horne CH
    J Pathol; 1991 Feb; 163(2):105-10. PubMed ID: 1673154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic impact of cathepsin D and c-erbB-2 oncoprotein in a subgroup of node-negative breast cancer patients with low histological grade tumors.
    Gaci Z; Bouin-Pineau MH; Gaci M; Daban A; Ingrand P; Métayé T
    Int J Oncol; 2001 Apr; 18(4):793-800. PubMed ID: 11251176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical expression of c-erbB-2 in human breast cancer by monoclonal antibody: correlation with lymph node and ER status.
    Querzoli P; Marchetti E; Fabris G; Marzola A; Ferretti S; Iacobelli S; Hazan R; King CR; Nenci I
    Tumori; 1990 Oct; 76(5):461-4. PubMed ID: 1979454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C-erbB-2 oncoprotein amplification in infiltrating ductal carcinoma of breast relates to high histological grade and loss of oestrogen receptor protein.
    Looi LM; Cheah PL
    Malays J Pathol; 1998 Jun; 20(1):19-23. PubMed ID: 10879259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen and progesterone receptors, c-erbB-2, p53, and Bcl-2 in thirty-three invasive micropapillary breast carcinomas.
    Luna-Moré S; de los Santos F; Bretón JJ; Cañadas MA
    Pathol Res Pract; 1996 Jan; 192(1):27-32. PubMed ID: 8685038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic and predictive relevance of c-erbB-2 and ras expression in node positive and negative breast cancer.
    Giai M; Roagna R; Ponzone R; De Bortoli M; Dati C; Sismondi P
    Anticancer Res; 1994; 14(3B):1441-50. PubMed ID: 7915096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. c-erB-2 oncoprotein expression in malignant and nonmalignant breast tissue.
    McCann A; Johnston PA; Dervan PA; Gullick WJ; Carney DN
    Ir J Med Sci; 1989 Jun; 158(6):137-40. PubMed ID: 2570047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer.
    Barbareschi M; Leonardi E; Mauri FA; Serio G; Dalla Palma P
    Am J Clin Pathol; 1992 Oct; 98(4):408-18. PubMed ID: 1357956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. c-erbB-2 oncoprotein expression in primary human tumors.
    McCann A; Dervan PA; Johnston PA; Gullick WJ; Carney DN
    Cancer; 1990 Jan; 65(1):88-92. PubMed ID: 2403483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of c-erbB-2 expression in breast carcinomas with clinical follow-up.
    Thor AD; Schwartz LH; Koerner FC; Edgerton SM; Skates SJ; Yin S; McKenzie SJ; Panicali DL; Marks PJ; Fingert HJ
    Cancer Res; 1989 Dec; 49(24 Pt 1):7147-52. PubMed ID: 2573426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.